A Study of SHR-1702 Alone or With Camrelizumab in Participants With Advanced Relapsed/Refractory Solid Tumors

Clinical trial NCT03871855 · TERMINATED

Trial details

NCT number: NCT03871855
Sponsor: Jiangsu HengRui Medicine Co., Ltd.
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumor

Start date: 2019-04-28
Primary completion: 2021-06-21
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.